ImmunoCellular Therapeutics
Immunocellular Therapeutics’ work in industry-leading, next-generation cancer vaccine immunotherapies.
Launch date
Employees
Market cap
$15.6m
Enterprise valuation
$16m (Public information from Sep 2024)
Share price
$0.079 IMUC
Calabasas California (HQ)
Authorizing premium user...